APO-Pemetrexed pemetrexed 500 mg (as disodium) powder for injection vial

Negara: Australia

Bahasa: Inggris

Sumber: Department of Health (Therapeutic Goods Administration)

Bahan aktif:

pemetrexed disodium hemipentahydrate, Quantity: 604 mg (Equivalent: pemetrexed, Qty 500 mg)

Tersedia dari:

Arrotex Pharmaceuticals Pty Ltd

INN (Nama Internasional):

pemetrexed disodium hemipentahydrate

Bentuk farmasi:

Injection, powder for

Komposisi:

Excipient Ingredients: sodium hydroxide; hydrochloric acid; mannitol

Rute administrasi :

Intravenous Infusion

Unit dalam paket:

1

Jenis Resep:

(S4) Prescription Only Medicine

Indikasi Terapi:

Malignant Pleural Mesothelioma,Pemetrexed, in combination with cisplatin, is indicated for the treatment of patients with malignant pleural mesothelioma.,Non-Small Cell Lung Cancer (NSCLC),Pemetrexed, in combination with cisplatin, is indicated for initial treatment of patients with locally advanced or metastatic NSCLC other than predominantly squamous cell histology.,Pemetrexed, as monotherapy, is indicated for the treatment of patients with locally advanced or metastatic NSCLC other than predominantly squamous cell histology after prior platinum-based chemotherapy.

Ringkasan produk:

Visual Identification: White to either light yellow or green-yellow powder.; Container Type: Vial; Container Material: Glass; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Status otorisasi:

Registered

Tanggal Otorisasi:

2014-09-04